PRESS RELEASE published on 07/09/2024 at 20:45, 2 years 1 month ago Inside Information / News release on accounts, results Acticor Biotech publishes its 2023 annual results, financial highlights, and financing outlook. Annual General Meeting scheduled for September 13, 2024 Annual General Meeting Financial Highlights 2023 Annual Results ACTICOR BIOTECH Financing Outlook
PRESS RELEASE published on 07/09/2024 at 20:45, 2 years 1 month ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers annuels pour 2023, avec une perte nette de 18,640 K€. La trésorerie s'élève à 3,9 M€. L'AG se tiendra le 13 septembre 2024 Résultats Financiers Assemblée Générale Trésorerie Perte Nette ACTICOR BIOTECH
BRIEF published on 05/15/2024 at 11:20, 2 years 3 months ago Résultats de l'étude ACTISAVE et perspectives futures d'ACTICOR BIOTECH ACTICOR BIOTECH Étude ACTISAVE Traitement AVC Glenzocimab ESOC 2024
BRIEF published on 05/15/2024 at 11:20, 2 years 3 months ago Results of the ACTISAVE study and future perspectives of ACTICOR BIOTECH Stroke Treatment ACTICOR BIOTECH Glenzocimab ESOC 2024 ACTISAVE Study
PRESS RELEASE published on 05/15/2024 at 11:15, 2 years 3 months ago Informations privilégiées / Autres communiqués ACTICOR BIOTECH présente les résultats de l'étude ACTISAVE sur le traitement de l'AVC ischémique lors de l'ESOC 2024. Perspectives prometteuses pour le glenzocimab malgré l'absence d'efficacité globale ACTICOR BIOTECH Glenzocimab ESOC 2024 AVC Ischémique ACTISAVE
PRESS RELEASE published on 05/15/2024 at 11:15, 2 years 3 months ago Inside Information / Other news releases ACTICOR BIOTECH presents main results of phase 2/3 ACTISAVE study on stroke treatment at ESOC 2024, targeting specific subgroups for potential benefits Stroke Treatment ACTICOR BIOTECH ESOC 2024 ACTISAVE Study Patient Subgroups
Published on 08/19/2026 at 04:00, 2 hours 31 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 7 hours 21 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 10 hours 46 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 12 hours 1 minute ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 12 hours 51 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/19/2026 at 06:00, 31 minutes ago Résultat semestriel 2026 : Implenia augmente sa rentabilité, son carnet de commandes et son flux de trésorerie disponible
Published on 08/19/2026 at 06:00, 31 minutes ago Half-year results 2026: Implenia increases profitability, order book and free cash flow
Published on 08/18/2026 at 22:00, 8 hours 31 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 8 hours 41 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 11 hours 31 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:00, 12 hours 31 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 12 hours 46 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 19 hours 16 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 19 hours 16 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 10 hours ago Aéroports de Paris S.A - July 2026 traffic figures
